← All stocks

DGX vs GH

Quest Diagnostics Incorporated Common Stock vs Guardant Health Inc. Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
DGX
GH
Composite score
Out of 100
70
50
Growth
60
64
Value
58
10
Quality
63
29
Momentum
97
97
Valuation
DGX
GH
Price
246.45
179.38
Market cap
27.20B
24.07B
Trailing P/E
26.19
0.00
Forward P/E
20.53
0.00
EV / EBITDA
14.63
-5.40
Dividend yield
1.3%
0.0%
Profitability
DGX
GH
ROE
14.6%
-45.8%
Net margin
9.2%
-38.3%
Debt / equity
0.82
-15.42
Free cash flow
1.36B
-233.07M
Growth
DGX
GH
Revenue growth (YoY)
10.2%
44.3%
Earnings growth (YoY)
15.0%
0.0%
Analyst target
247.40
195.81
See full analysis